Olympic Athletes to Receive Vaccines Donated by Pfizer, BioNTech
(Bloomberg) -- Tokyo Olympic athletes and delegations will be able to receive Covid-19 vaccine doses donated by Pfizer Inc. and BioNTech SE as organizers push ahead with preparations for the delayed games.
The International Olympic Committee signed an agreement with the companies to donate the doses, with the first delivery expected to begin at the end of this month, according to a statement from the drugmakers on Thursday. The statement did not specify the number of doses.
While the IOC has said vaccination is not a requirement for athletes to participate in the games, the spread of more contagious variants and the resurgence of infections in some countries have raised questions over the safety of holding the world's biggest sporting event in less than three months.
Even with the decision to exclude foreign spectators, more than 60,000 athletes, coaches, national team staff, media representatives and other essential workers are expected to converge on Tokyo from more than 200 countries when the games start in July.
Public support is low in the host country, where just 1.4% of its population has been given doses -- the lowest among the 37 members of the Organization for Economic Cooperation and Development, according to Bloomberg's vaccine tracker.
About 73% of those surveyed in Japan over April 17-18 said they were against holding the event this summer, according to a poll conducted by broadcaster ANN. As of Thursday, more than 100,000 people signed an online petition calling for the games to be called off.
With Covid cases on the rise, Tokyo Governor Yuriko Koike told reporters earlier in the day she would propose extending the state of emergency, set to end May 11, to the end of this month. Japanese Prime Minister Yoshihide Suga said he would decide Friday on the extension for the capital and three other regions.
The national Olympic committees will work with their local governments to coordinate local distribution of the Pfizer vaccine, the IOC said in a statement, while Olympic Minister Tamayo Marukawa welcomed the agreement. The IOC drew criticism from human rights activists in March after President Thomas Bach said that the organization was ready to pay for vaccines offered by China to protect athletes and officials from countries that have approved that nation's shots.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.